ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,321,084 | +34.7% | 205,360 | +74.4% | 0.01% | +50.0% |
| Q2 2023 | $5,433,191 | +37.2% | 117,780 | +19.2% | 0.01% | +20.0% |
| Q1 2023 | $3,960,998 | -34.3% | 98,778 | -24.1% | 0.01% | -28.6% |
| Q4 2022 | $6,029,850 | -43.3% | 130,150 | -50.4% | 0.01% | -46.2% |
| Q3 2022 | $10,639,000 | -41.4% | 262,364 | -13.8% | 0.01% | -38.1% |
| Q2 2022 | $18,150,000 | -30.3% | 304,227 | -15.1% | 0.02% | -12.5% |
| Q1 2022 | $26,023,000 | -17.2% | 358,341 | -4.1% | 0.02% | -7.7% |
| Q4 2021 | $31,430,000 | +42.9% | 373,771 | +53.2% | 0.03% | +13.0% |
| Q3 2021 | $22,002,000 | +17.6% | 243,947 | +4.1% | 0.02% | +21.1% |
| Q2 2021 | $18,709,000 | -27.7% | 234,360 | +3.1% | 0.02% | -34.5% |
| Q1 2021 | $25,877,000 | +3.6% | 227,267 | +25.9% | 0.03% | -3.3% |
| Q4 2020 | $24,984,000 | +122.1% | 180,478 | +31.9% | 0.03% | +87.5% |
| Q3 2020 | $11,247,000 | +30.3% | 136,842 | +24.0% | 0.02% | +33.3% |
| Q2 2020 | $8,631,000 | +173.6% | 110,342 | +55.4% | 0.01% | +140.0% |
| Q1 2020 | $3,155,000 | +4.0% | 71,016 | -0.1% | 0.01% | +25.0% |
| Q4 2019 | $3,035,000 | -5.6% | 71,070 | -5.5% | 0.00% | -20.0% |
| Q3 2019 | $3,216,000 | -39.1% | 75,170 | -9.6% | 0.01% | -37.5% |
| Q2 2019 | $5,281,000 | +17.5% | 83,170 | +28.3% | 0.01% | +14.3% |
| Q1 2019 | $4,496,000 | +79.7% | 64,820 | +12.7% | 0.01% | +75.0% |
| Q4 2018 | $2,502,000 | -44.6% | 57,539 | -2.7% | 0.00% | -42.9% |
| Q3 2018 | $4,515,000 | -1.1% | 59,139 | -0.4% | 0.01% | 0.0% |
| Q2 2018 | $4,565,000 | +94.7% | 59,381 | +29.1% | 0.01% | +75.0% |
| Q1 2018 | $2,345,000 | +22.3% | 45,994 | +11.3% | 0.00% | +33.3% |
| Q4 2017 | $1,917,000 | +13.8% | 41,328 | +30.7% | 0.00% | 0.0% |
| Q3 2017 | $1,685,000 | -28.1% | 31,628 | -16.2% | 0.00% | -25.0% |
| Q2 2017 | $2,343,000 | -4.3% | 37,728 | +4.4% | 0.00% | 0.0% |
| Q1 2017 | $2,449,000 | -10.1% | 36,128 | -6.7% | 0.00% | -20.0% |
| Q4 2016 | $2,723,000 | -0.6% | 38,728 | +0.3% | 0.01% | 0.0% |
| Q3 2016 | $2,740,000 | +68.6% | 38,628 | +16.3% | 0.01% | +66.7% |
| Q2 2016 | $1,625,000 | -5.9% | 33,219 | +21.8% | 0.00% | 0.0% |
| Q1 2016 | $1,726,000 | -45.6% | 27,265 | -3.5% | 0.00% | -50.0% |
| Q4 2015 | $3,171,000 | +13.7% | 28,265 | -2.4% | 0.01% | +20.0% |
| Q3 2015 | $2,790,000 | +11.5% | 28,965 | +18.5% | 0.01% | +25.0% |
| Q2 2015 | $2,502,000 | +64.9% | 24,434 | 0.0% | 0.00% | +33.3% |
| Q1 2015 | $1,517,000 | +54.2% | 24,434 | +8.9% | 0.00% | +50.0% |
| Q4 2014 | $984,000 | -8.0% | 22,434 | +18.8% | 0.00% | 0.0% |
| Q3 2014 | $1,069,000 | +276.4% | 18,884 | +225.6% | 0.00% | +100.0% |
| Q1 2014 | $284,000 | – | 5,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |